MedPage Today on MSN
Cardiologist's Fake Cancer; Gene Therapy Trial Resumes; More Impella Woes
Recent developments of interest in cardiovascular medicine ...
Add Yahoo as a preferred source to see more of our stories on Google. Abiomed's Impella 2.5 heart pump helps maintain blood flow during high-risk heart procedures or cardiac shock. Johnson & Johnson ...
The FDA today issued a warning related to certain heart pump technologies made by Johnson & Johnson MedTech's Abiomed unit.
MERIDIAN, Miss. — Patients in Mississippi previously turned away for heart surgery may have another option in the Impella 2.5, the world's smallest heart pump — now available for elderly, unstable or ...
Oct 11 (Reuters) - Abiomed Inc said U.S. health regulators has requested additional information related to the company's submission for clearance of its circulatory support system Impella 2.5. The ...
DANVERS, Mass. – October 24, 2024 – Novel data on the benefits of Impella ® heart pump technology in high-risk percutaneous coronary intervention (PCI) and cardiogenic shock will be presented during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results